Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Discovering the full spectrum of cardiovascular disease: Minority Health Summit 2003: executive summary.

Yancy CW, Benjamin EJ, Fabunmi RP, Bonow RO.

Circulation. 2005 Mar 15;111(10):1339-49. No abstract available.

PMID:
15769779
2.

National study of physician awareness and adherence to cardiovascular disease prevention guidelines.

Mosca L, Linfante AH, Benjamin EJ, Berra K, Hayes SN, Walsh BW, Fabunmi RP, Kwan J, Mills T, Simpson SL.

Circulation. 2005 Feb 1;111(4):499-510.

PMID:
15687140
3.

Opportunity for intervention to achieve American Heart Association guidelines for optimal lipid levels in high-risk women in a managed care setting.

Mosca L, Merz NB, Blumenthal RS, Cziraky MJ, Fabunmi RP, Sarawate C, Watson KE, Willey VJ, Stanek EJ.

Circulation. 2005 Feb 1;111(4):488-93.

PMID:
15687138
4.

Atherosclerotic Vascular Disease Conference: Writing Group III: pathophysiology.

Faxon DP, Fuster V, Libby P, Beckman JA, Hiatt WR, Thompson RW, Topper JN, Annex BH, Rundback JH, Fabunmi RP, Robertson RM, Loscalzo J; American Heart Association.

Circulation. 2004 Jun 1;109(21):2617-25. Review. No abstract available.

PMID:
15173044
5.

Evidence-based guidelines for cardiovascular disease prevention in women. American Heart Association scientific statement.

Mosca L, Appel LJ, Benjamin EJ, Berra K, Chandra-Strobos N, Fabunmi RP, Grady D, Haan CK, Hayes SN, Judelson DR, Keenan NL, McBride P, Oparil S, Ouyang P, Oz MC, Mendelsohn ME, Pasternak RC, Pinn VW, Robertson RM, Schenck-Gustafsson K, Sila CA, Smith SC Jr, Sopko G, Taylor AL, Walsh BW, Wenger NK, Williams CL; AHA.

Arterioscler Thromb Vasc Biol. 2004 Mar;24(3):e29-50. Review. No abstract available.

PMID:
15003974
6.

Evidence-based guidelines for cardiovascular disease prevention in women.

Mosca L, Appel LJ, Benjamin EJ, Berra K, Chandra-Strobos N, Fabunmi RP, Grady D, Haan CK, Hayes SN, Judelson DR, Keenan NL, McBride P, Oparil S, Ouyang P, Oz MC, Mendelsohn ME, Pasternak RC, Pinn VW, Robertson RM, Schenck-Gustafsson K, Sila CA, Smith SC Jr, Sopko G, Taylor AL, Walsh BW, Wenger NK, Williams CL; American Heart Association; American College of Cardiology; American College of Nurse Practitioners; Amercian College of Obstetricians and Gynecologists; American College of Physicians; American Medical Women's Association; Association of Black Cardiologists; Centers for Disease Control and Prevention; National Heart, Lung and Blood Institute, National Institutes of Health; Office of Research on Women's Health; Sociey of Thoracic Surgeons; World Heart Federation.

J Am Coll Cardiol. 2004 Mar 3;43(5):900-21. No abstract available.

7.

Evidence-based guidelines for cardiovascular disease prevention in women.

Mosca L, Appel LJ, Benjamin EJ, Berra K, Chandra-Strobos N, Fabunmi RP, Grady D, Haan CK, Hayes SN, Judelson DR, Keenan NL, McBride P, Oparil S, Ouyang P, Oz MC, Mendelsohn ME, Pasternak RC, Pinn VW, Robertson RM, Schenck-Gustafsson K, Sila CA, Smith SC Jr, Sopko G, Taylor AL, Walsh BW, Wenger NK, Williams CL; American Heart Association.

Circulation. 2004 Feb 10;109(5):672-93. Epub 2004 Feb 4. No abstract available.

PMID:
14761900
8.

Interferon gamma regulates accumulation of the proteasome activator PA28 and immunoproteasomes at nuclear PML bodies.

Fabunmi RP, Wigley WC, Thomas PJ, DeMartino GN.

J Cell Sci. 2001 Jan;114(Pt 1):29-36.

9.

Stromelysin-1 (MMP-3) expression driven by a macrophage-specific promoter results in reduced viability in transgenic mice.

Fabunmi RP, Moore KJ, Libby P, Freeman MW.

Atherosclerosis. 2000 Feb;148(2):375-86.

PMID:
10657574
10.

Activity and regulation of the centrosome-associated proteasome.

Fabunmi RP, Wigley WC, Thomas PJ, DeMartino GN.

J Biol Chem. 2000 Jan 7;275(1):409-13.

11.

Dynamic association of proteasomal machinery with the centrosome.

Wigley WC, Fabunmi RP, Lee MG, Marino CR, Muallem S, DeMartino GN, Thomas PJ.

J Cell Biol. 1999 May 3;145(3):481-90.

12.

T lymphocytes induce endothelial cell matrix metalloproteinase expression by a CD40L-dependent mechanism: implications for tubule formation.

Mach F, Schönbeck U, Fabunmi RP, Murphy C, Atkinson E, Bonnefoy JY, Graber P, Libby P.

Am J Pathol. 1999 Jan;154(1):229-38.

13.

Use of liposome-mediated DNA transfection to determine promoter activity in smooth muscle cells.

Fabunmi RP.

Methods Mol Med. 1999;30:143-50. doi: 10.1385/1-59259-247-3:143.

PMID:
21341022
14.

In vitro-differentiated embryonic stem cell macrophages: a model system for studying atherosclerosis-associated macrophage functions.

Moore KJ, Fabunmi RP, Andersson LP, Freeman MW.

Arterioscler Thromb Vasc Biol. 1998 Oct;18(10):1647-54.

PMID:
9763539
17.

Regulation of matrix metalloproteinase expression in human vascular smooth muscle cells by T lymphocytes: a role for CD40 signaling in plaque rupture?

Schönbeck U, Mach F, Sukhova GK, Murphy C, Bonnefoy JY, Fabunmi RP, Libby P.

Circ Res. 1997 Sep;81(3):448-54.

PMID:
9285647
18.

Upregulation of basement membrane-degrading metalloproteinase secretion after balloon injury of pig carotid arteries.

Southgate KM, Fisher M, Banning AP, Thurston VJ, Baker AH, Fabunmi RP, Groves PH, Davies M, Newby AC.

Circ Res. 1996 Dec;79(6):1177-87.

PMID:
8943956
20.

Neointimal fibrosis in vascular pathologies: role of growth factors and metalloproteinases in vascular smooth muscle proliferation.

Newby AC, Fabunmi RP, George SJ, Southgate KM, Banning AP, Thurston VJ, Williams A.

Exp Nephrol. 1995 Mar-Apr;3(2):108-13. Review. No abstract available.

PMID:
7773629

Supplemental Content

Loading ...
Support Center